Australia markets close in 20 minutes

Global Bioenergies SA (ALGBE.PA)

Paris - Paris Delayed price. Currency in EUR
Add to watchlist
1.8140-0.0220 (-1.20%)
At close: 05:35PM CEST
Full screen
Previous close1.8360
Open1.8100
BidN/A x N/A
AskN/A x N/A
Day's range1.7700 - 1.8400
52-week range1.7020 - 4.3700
Volume15,869
Avg. volume19,681
Market cap32.818M
Beta (5Y monthly)1.45
PE ratio (TTM)N/A
EPS (TTM)N/A
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • GlobeNewswire

    Global Bioenergies ISO 9001 certified

    PRESS RELEASE Global Bioenergies ISO 9001 certified Evry, 16 April 2024 – 05:45 p.m.: Global Bioenergies (FR0011052257 – ALGBE), a player in industrial biotechnology, announces its ISO 9001:2015 certification, the benchmark for quality worldwide. This certification is the result of 3 years of efforts led by the Company in the implementation of its production and marketing activities. Its main objectives are to ensure the quality of products sold and customer satisfaction, in order to respond ful

  • GlobeNewswire

    Global Bioenergies has received letters of intent for its plant project corresponding to forecasted annual sales of over €70 million

    PRESS RELEASE Global Bioenergies has received letters of intent for itsplant project corresponding to forecasted annual salesof over €70 million The plant will focus on high added-value cosmetics markets, with annual production capacity rescaled to 2,500 tons The total volume of letters of intent exceeds the plant's production capacityThe plant will also enable to initiate the sustainable aviation fuels market CAPEX and plant design specifications clarified Evry, 08 April 2024 – 5:45 pm CEST: Gl

  • GlobeNewswire

    Global Bioenergies: strong reduction of the loss in 2023 thanks to a significant increase in commercial activity

    PRESS RELEASE Global Bioenergies: strong reduction of the loss in 2023 thanks to a significant increase in commercial activity Sales exceeding €3M for the first timeConsolidated net loss significantly improved to -€8.7M compared to -€12M in 2022Gross cash position of €11.7M at 31 December 2023 compared to €8.8M the previous yearSuccessful commercialization of the first tons of Isonaturane™ 12 to several customers including L'OréalASTM certification received for the production of sustainable avia